Top

Published in:

01-06-2010 | NON-THEMATIC REVIEW

Bacterial infections associated with cancer: possible implication in etiology with special reference to lateral gene transfer

Authors: Abdul Arif Khan, Abhinav Shrivastava

Published in: Cancer and Metastasis Reviews | Issue 2/2010

Abstract

Bacteria are capable of exchanging DNA between each other and even from other organisms including human, but what will be the fate of such exchange? Enigmatic association between bacterial infections and cancer is also demonstrated recently with unknown exact cause and effect mechanism. This enigma may be resolved not in all but in few cases with the view of horizontal DNA transfer. The present article tries to examine this association in the frame of new idea. This article concludes that knowledge of this association may aid in management of cancer in clinical settings.

Doolittle, W. F. (1998). You are what you eat: a gene transfer ratchet could account for bacterial genes in eukaryotic nuclear genomes. Trends in Genetics, 14, 307–311.CrossRefPubMed

Martin, W., & Herrmann, R. G. (1998). Gene transfer from organelles to the nucleus: how much, what happens, and why? Plant Physiology, 118, 9–17.CrossRefPubMed

Nelson, K. E., et al. (1999). Evidence for lateral gene transfer between Archaea and Bacteria from genome sequence of Thermotoga maritima. Nature, 399, 323.CrossRefPubMed

Worning, P., Jensen, L. J., Nelson, K. E., Brunak, S., & Ussery, D. W. (2000). Structural analysis of DNA sequence: evidence for lateral gene transfer in Thermotoga maritima. Nucleic Acids Research, 28, 706–709.CrossRefPubMed

Da Lage, J. L., Feller, G., & Janecek, S. (2004). Horizontal gene transfer from Eukarya to bacteria and domain shuffling: the alpha-amylase model. Cellular and Molecular Life Sciences, 61, 97–109.CrossRefPubMed

Garcia-Vallve, S., Romeu, A., & Palau, J. (2000). Horizontal gene transfer of glycosyl hydrolases of the rumen fungi. Molecular Biology and Evolution, 17, 352–361.PubMed

Devillard, E., et al. (1999). A xylanase produced by the rumen anaerobic protozoan Polyplastron multivesiculatum shows close sequence similarity to family 11 xylanases from gram-positive bacteria. FEMS Microbiology Letters, 181, 145–152.CrossRefPubMed

Scholl, E. H., Thorne, J. L., McCarter, J. P., & Bird, D. M. (2003). Horizontally transferred genes in plant-parasitic nematodes: a high-throughput genomic approach. Genome Biology, 4, R39.CrossRefPubMed

Loftus, B., et al. (2005). The genome of the protist parasite Entamoeba histolytica. Nature, 433, 865–868.CrossRefPubMed

10.

Ponting, C. P. (2001). Plagiarized bacterial genes in the human book of life. Trends in Genetics, 17(5), 235–237.CrossRefPubMed

11.

Lander, E. S., et al. (2001). Initial sequencing and analysis of the human genome. Nature, 409, 860–921.CrossRefPubMed

12.

Crowe, S. E. (2005). Helicobacter infection, chronic inflammation, and the development of malignancy. Current Opinion in Gastroenterology, 1, 32–38.

13.

Montalban, C., Santon, A., Boixeda, D., & Bellas, C. (2001). Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication. Gut, 49, 584–587.CrossRefPubMed

14.

Persing, D. H., & Prendergast, F. G. (1999). Infection, immunity, and cancer. Archives of Pathology and Laboratory Medicine, 123, 1015–1022.PubMed

15.

Vaishnavi, C., et al. (2005). Epidemiology of typhoid carriers among blood donors and patients with biliary, gastrointestinal and other related diseases. Microbiology and Immunology, 49, 107–112.PubMed

16.

Lax, A. J., & Thomas, W. (2002). How bacteria could cause cancer: one step at a time. Trends in Microbiology, 10, 293–299.CrossRefPubMed

17.

Dutta, U., Garg, P. K., Kumar, R., & Tandon, R. K. (2000). Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. American Journal of Gastroenterology, 95, 784–787.CrossRefPubMed

18.

Shukla, V. K., Singh, H., Pandey, M., Upadhyay, S. K., & Nath, G. (2000). Carcinoma of the gallbladder—is it a sequel of typhoid? Digestive Diseases and Sciences, 45, 900–903.CrossRefPubMed

19.

Biarc, J., et al. (2004). Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius formerly S. bovis). Carcinogenesis, 25, 1477–1484.CrossRefPubMed

20.

Gold, J. S., Bayar, S., & Salem, R. R. (2004). Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Archives of Surgery, 139, 760–765.CrossRefPubMed

21.

Ellmerich, S., et al. (2000). Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis, 21, 753–756.CrossRefPubMed

22.

Zarkin, B. A., et al. (1990). The triad of Streptococcus bovis bacteremia, colonic pathology, and liver disease. Annals of Surgery, 211, 786–791.CrossRefPubMed

23.

Littman, A. J., et al. (2004). Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiology, Biomarkers and Prevention, 13, 1624–1630.PubMed

24.

Koyi, H., et al. (2001). An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study. Acta Pathologica, Microbiologica et Immunologica Scandinavica, 109, 572–580.

25.

Anttila, T., et al. (2003). Chlamydia pneumoniae infection and the risk of female early-onset lung cancer. International Journal of Cancer, 107, 681–682.CrossRef

26.

Kamboj, M., & Sepkowitz, K. A. (2009). Nosocomial infections in patients with cancer. Lancet Oncology, 10(6), 589–597.CrossRefPubMed

27.

Russell, W. (1890). An address on a characteristic organism of cancer. British Medical Journal, 2, 1356–1360.CrossRef

28.

Glover, T. J. (1926). Progress in Cancer Research. Canada Lancet and Practitioner, 67, 5.

29.

Glover, T. J. (1930). The bacteriology of cancer. Canada Lancet and Practitioner, 74, 92–111.

30.

Glover, T. J., & Engle, J. L. (1938). Studies in malignancy. New York: Murdock Foundation.

31.

Diller, I. C., & Diller, W. F. (1965). Intracellular acid-fast organisms isolated from malignant tissues. Transactions of the American Microscopical Society, 84(1), 138–148.CrossRefPubMed

32.

Schoppmann, S. F., et al. (2002). Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. American Journal of Pathology, 161, 947–956.PubMed

33.

Sheng, H., Shao, J., Washington, M. K., & DuBois, R. N. (2001). Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. Journal of Biological Chemistry, 276, 18075–18081.CrossRefPubMed

34.

Mannick, E. E., et al. (1996). Inducible nitric oxide synthase, nitrotyrosine and apoptosis in Helicobacter pylori gastritis: effects of antibiotics and antioxidants. Cancer Research, 56, 3238–3243.PubMed

35.

zur Hausen, H. (1991). Viruses in human cancers. Science, 254(5035), 1167–1173.CrossRefPubMed

36.

Costello, L. C., & Franklin, R. B. (2006). Tumor cell metabolism: the marriage of molecular genetics and proteomics with cellular intermediary metabolism; proceed with caution! Molecular Cancer, 5, 59.CrossRefPubMed

37.

Malfertheiner, P., et al. (2005). Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. American Journal of Gastroenterology, 100, 2100–2115.CrossRefPubMed

38.

Lazcano-Ponce, E. C., et al. (2001). Epidemiology and molecular pathology of gallbladder cancer. CA: A Cancer Journal for Clinicians, 51, 349–364.CrossRef

39.

Laurila, A. L., Von Hertzen, L., & Saikku, P. (1997). Chlamydia pneumoniae and chronic lung diseases. Scandinavian Journal of Infectious Diseases, 104, 34–36.PubMed

40.

Moger, D. (2006). Bacteria and cancer: cause, coincidence or cure? A review. Journal of Translational Medicine, 4, 14.CrossRef

41.

Rolston, K. V. (2009). New antimicrobial agents for the treatment of bacterial infections in cancer patients. Hematological Oncology, 27(3), 107–114.CrossRefPubMed

42.

Ward, J. M., et al. (1994). Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. Journal of the National Cancer Institute, 86, 1222–1227.CrossRefPubMed

43.

Maggio-Price, L., et al. (2006). Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Research, 66, 828–838.CrossRefPubMed

44.

Newman, J. V., Kosaka, T., Sheppard, B. J., Fox, J. G., & Schauer, D. B. (2001). Bacterial infection promotes colon tumorigenesis in Apc(Min/+) mice. Journal of Infectious Diseases, 184, 227–230.CrossRefPubMed

45.

Wistuba, I. I., & Gazdar, A. F. (2004). Gallbladder cancer: lessons from a rare tumour. Nature Reviews Cancer, 4, 695–706.CrossRefPubMed

46.

Hotopp, J. C., et al. (2007). Widespread lateral gene transfer from intracellular bacteria to multicellular eukaryotes. Science, 317, 1753–1756.CrossRefPubMed

47.

Porwollik, S., & McClelland, M. (2003). Lateral gene transfer in Salmonella. Microbes and Infection, 5(11), 977–989.CrossRefPubMed

48.

DeMars, R., Weinfurter, J., Guex, E., Lin, J., & Potucek, Y. (2007). Lateral gene transfer in vitro in the intracellular pathogen Chlamydia trachomatis. Journal of Bacteriology, 189(3), 991–1003.CrossRefPubMed

49.

Griffin, L. D., & Kellam, P. (2009). Infectious causes of cancer and their detection. Journal of Biology, 8, 67.CrossRef

50.

Stein, L., et al. (2008). The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995-2004. International Journal of Cancer, 122, 2260–2265.CrossRef

51.

Parsonnet, J. (1995). Bacterial infection as a cause of cancer. Environmental Health Perspectives, 103, 263–268.CrossRefPubMed

52.

Schetter, A. J., Heegaard, N. H., & Harris, C. C. (2010). Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis, 31(1), 37–49.CrossRefPubMed

53.

Markowitz, S. D., & Bertagnolli, M. M. (2009). Molecular basis of colorectal cancer. New England Journal of Medicine, 361(25), 2449–2460.CrossRefPubMed

54.

Lam, S. T., & Roth, J. R. (1983). IS200: Salmonella specific insertion sequence. Cell, 34, 951–960.CrossRefPubMed

55.

Beuzón, C. R., & Casadesús, J. (1997). Conserved structure of IS200 element in Salmonella. Nucleic Acids Research, 25(7), 1355–1361.CrossRefPubMed

56.

Salzberg, S. L., White, O., Peterson, J., & Eisen, J. A. (2001). Microbial genes in human genome: lateral gene transfer or gene loss. Science, 292, 1903–1906.CrossRefPubMed

57.

Andersson, J. O., et al. (2001). Genomics. Are their bugs in our genome? Science, 292, 1848–1850.CrossRefPubMed

58.

Margulis, L., & Sagan, D. (2002). Acquiring genomes: a theory of the origins of species. New York: Basic Books.

59.

Ferguson, G. C., Heinemann, J. A., & Kennedy, M. A. (2002). Gene transfer between Salmonella enterica serovar Typhimurium inside epithelial cells. Journal of Bacteriology, 184(8), 2235–2242.CrossRefPubMed

60.

Ragan, M. A. (2001). Detection of lateral gene transfer among microbial genomes. Current Opinion in Genetics & Development, 11, 620–626.CrossRef

61.

Mager, D. L., Haffajee, A. D., Devlin, P. M., Norris, Posner, M. R., & Goodson, J. M. (2005). The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non randomized study of cancer free and oral squamus cell carcinoma subject. Journal of Translational Medicine, 3, 27.CrossRefPubMed

62.

Bronowski, C., Smith, S. L., Yokota, K., Corkill, J. E., Martin, H. M., Campbell, B. J., et al. (2008). A subset of mucosa associated Escherichia coli isolates from patients with colon cancer, but not Crohn's disease, share pathogenecity island with urinary pathogenic E. coli. Microbiology, 154, 571–583.CrossRefPubMed

Title: Bacterial infections associated with cancer: possible implication in etiology with special reference to lateral gene transfer
Authors: Abdul Arif Khan
Abhinav Shrivastava
Publication date: 01-06-2010
Publisher: Springer US
Published in: Cancer and Metastasis Reviews / Issue 2/2010
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-010-9217-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2010

Senescent cells as a source of inflammatory factors for tumor progression

Why not treat human cancer with interleukin-1 blockade?

Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity

Metastasis: cancer cell’s escape from oxidative stress

TGFβ and cancer metastasis: an inflammation link

Biography—Alberto Mantovani, MD

Keynote webinar | Spotlight on antibody–drug conjugates in cancer